Literature DB >> 33635872

Histone H4 potentiates neutrophil inflammatory responses to influenza A virus: Down-modulation by H4 binding to C-reactive protein and Surfactant protein D.

I-Ni Hsieh1, Mitchell White1, Marloes Hoeksema2, Xavier Deluna1, Kevan Hartshorn1.   

Abstract

Neutrophils participate in the early phase of the innate response to uncomplicated influenza A virus (IAV) infection but also are a major component in later stages of severe IAV or COVID 19 infection where neutrophil extracellular traps (NETs) and associated cell free histones are highly pro-inflammatory. It is likely that IAV interacts with histones during infection. We show that histone H4 binds to IAV and aggregates viral particles. In addition, histone H4 markedly potentiates IAV induced neutrophil respiratory burst responses. Prior studies have shown reactive oxidants to be detrimental during severe IAV infection. C reactive protein (CRP) and surfactant protein D (SP-D) rise during IAV infection. We now show that both of these innate immune proteins bind to histone H4 and significantly down regulate respiratory burst and other responses to histone H4. Isolated constructs composed only of the neck and carbohydrate recognition domain of SP-D also bind to histone H4 and partially limit neutrophil responses to it. These studies indicate that complexes formed of histones and IAV are a potent neutrophil activating stimulus. This finding could account for excess inflammation during IAV or other severe viral infections. The ability of CRP and SP-D to bind to histone H4 may be part of a protective response against excessive inflammation in vivo.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33635872      PMCID: PMC7909658          DOI: 10.1371/journal.pone.0247605

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  63 in total

1.  Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Robert Ruemmler; Norman F Russkamp; Firas S Zetoune; J Vidya Sarma; Theodore J Standiford; Peter A Ward
Journal:  FASEB J       Date:  2013-08-27       Impact factor: 5.191

Review 2.  Histones as mediators of host defense, inflammation and thrombosis.

Authors:  Marloes Hoeksema; Martin van Eijk; Henk P Haagsman; Kevan L Hartshorn
Journal:  Future Microbiol       Date:  2016-03-04       Impact factor: 3.165

3.  Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death.

Authors:  Carlos Silvestre-Roig; Quinte Braster; Kanin Wichapong; Ernest Y Lee; Jean Marie Teulon; Nihel Berrebeh; Janine Winter; José M Adrover; Giancarlo Santiago Santos; Alexander Froese; Patricia Lemnitzer; Almudena Ortega-Gómez; Raphael Chevre; Julian Marschner; Ariane Schumski; Carla Winter; Laura Perez-Olivares; Chang Pan; Nicole Paulin; Tom Schoufour; Helene Hartwig; Silvia González-Ramos; Frits Kamp; Remco T A Megens; Kerri A Mowen; Matthias Gunzer; Lars Maegdefessel; Tilman Hackeng; Esther Lutgens; Mat Daemen; Julia von Blume; Hans-Joachim Anders; Viacheslav O Nikolaev; Jean-Luc Pellequer; Christian Weber; Andrés Hidalgo; Gerry A F Nicolaes; Gerard C L Wong; Oliver Soehnlein
Journal:  Nature       Date:  2019-05-01       Impact factor: 49.962

4.  Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.

Authors:  A M LeVine; J A Whitsett; K L Hartshorn; E C Crouch; T R Korfhagen
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

5.  Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury.

Authors:  Hai Huang; Hui-Wei Chen; John Evankovich; Wei Yan; Brian R Rosborough; Gary W Nace; Qing Ding; Patricia Loughran; Donna Beer-Stolz; Timothy R Billiar; Charles T Esmon; Allan Tsung
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

6.  Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A.

Authors:  K Hartshorn; D Chang; K Rust; M White; J Heuser; E Crouch
Journal:  Am J Physiol       Date:  1996-11

7.  Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses.

Authors:  K L Hartshorn; E C Crouch; M R White; P Eggleton; A I Tauber; D Chang; K Sastry
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Interactions of alpha-, beta-, and theta-defensins with influenza A virus and surfactant protein D.

Authors:  Mona Doss; Mitchell R White; Tesfaldet Tecle; Donald Gantz; Erika C Crouch; Grace Jung; Piotr Ruchala; Alan J Waring; Robert I Lehrer; Kevan L Hartshorn
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

9.  SP-D attenuates LPS-induced formation of human neutrophil extracellular traps (NETs), protecting pulmonary surfactant inactivation by NETs.

Authors:  Raquel Arroyo; Meraj Alam Khan; Mercedes Echaide; Jesús Pérez-Gil; Nades Palaniyar
Journal:  Commun Biol       Date:  2019-12-16

10.  Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo.

Authors:  Johannes Westman; Praveen Papareddy; Madelene W Dahlgren; Bhavya Chakrakodi; Anna Norrby-Teglund; Emanuel Smeds; Adam Linder; Matthias Mörgelin; Bengt Johansson-Lindbom; Arne Egesten; Heiko Herwald
Journal:  PLoS Pathog       Date:  2015-12-08       Impact factor: 6.823

View more
  2 in total

Review 1.  Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes.

Authors:  Jacopo Sabbatinelli; Giulia Matacchione; Angelica Giuliani; Deborah Ramini; Maria Rita Rippo; Antonio Domenico Procopio; Massimiliano Bonafè; Fabiola Olivieri
Journal:  Mech Ageing Dev       Date:  2022-03-25       Impact factor: 5.498

2.  COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection.

Authors:  Eduardo Esteves; Vera M Mendes; Bruno Manadas; Rafaela Lopes; Liliana Bernardino; Maria José Correia; Marlene Barros; Ana Cristina Esteves; Nuno Rosa
Journal:  J Clin Med       Date:  2022-09-22       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.